Abstract
Histamine H4 receptors are expressed in immune cells, but their potential role in the brain is less clear. Although H4 transcripts have been identified in human and rat brain, the presence of H4 receptors on the protein level has so far not been proven since appropriate antibodies fulfilling the strict criteria for G protein-coupled receptors are missing. Here, we searched for functional H4 receptors in human, guinea pig and mouse cortex. We studied whether H4 receptor activation is associated with increased GTPγS binding and reduced noradrenaline release. The latter two effects have been previously shown for H3 receptors, which, like the H4 receptors, are coupled to G i/o protein. G protein activation was studied using 35S-GTPγS binding in cortical membranes. The electrically induced 3H-noradrenaline release was determined in superfused cortical slices. The H4 agonist 4-methylhistamine failed to affect 35S-GTPγS binding and/or noradrenaline release in human, guinea pig and mouse cortex although an H 3 receptor-mediated increase in 35S-GTPγS binding and inhibition of noradrenaline release occurred in parallel experiments. In conclusion, functional H4 receptors increasing 35S-GTPγS binding and/or decreasing noradrenaline release are not found in human, guinea pig and mouse cortex.
Similar content being viewed by others
References
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, Collaborators CGTP (2013) The concise guide to pharmacology 2013/14: G protein-coupled receptors. Br J Pharmacol 170:1459–1581
Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC (1987) Highly potent and selective ligands for histamine H3-receptors. Nature 327:117–123
Ballerini C, Aldinucci A, Luccarini I, Galante A, Manuelli C, Blandina P, Katebe M, Chazot PL, Masini E, Passani MB (2013) Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalitis. Br J Pharmacol 170:67–77
Beermann S, Seifert R, Neumann D (2012) Commercially available antibodies against human and murine histamine H4-receptor lack specificity. Naunyn-Schmiedeberg’s Arch Pharmacol 385:125–132
Boehm S, Kubista H (2002) Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54:43–99
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Chan NYK, Robador PA, Levi R (2012) Natriuretic peptide-induced catecholamine release from cardiac sympathetic neurons: inhibition by histamine H3 and H4 receptor activation. J Pharmacol Exp Ther 343:568–577
Connelly WM, Shenton FC, Lethbridge N, Leurs R, Waldvogel HJ, Faull RLM, Lees G, Chazot PL (2009) The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 157:55–63
Desmadryl G, Gaboard-Niay S, Brugeaud A, Travo C, Broussy A, Saleur A, Dyhrfjeld-Johnsen J, Wersinger E, Chabbert C (2012) Histamine H4 receptor antagonists as potent modulators of mammalian verstibular primary neuron excitability. Br J Pharmacol 167:905–916
Feliszek M, Schacht D, Schulte K, Jergas B, von Lehe M, Schlicker E (2012) Do histamine H2 and H4 receptors affect noradrenaline release in the human cerebral cortex? Naunyn-Schmiedeberg’s Arch Pharmacol 385(Suppl 1):S25
Feuerstein TJ (2008) Presynaptic receptors for dopamine, histamine, and serotonin. Handb Exp Pharmacol 168:289–338
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. Handb Exp Pharmacol 33:283–335
Galeotti N, Sanna MD, Ghelardini C (2013) Pleiotropic effect of histamine H4 receptor modulation in the central nervous system. Neuropharmacology 71:141–147
Hough LB (2001) Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 59:415–419
Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, Ly KS, Wei J, Baker SM, Desai PJ, Jiang W, Wilson SJ, Thurmond RL, Karlsson L, Edwards JP, Lovenberg TW, Carruthers NI (2003) The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 46:3957–3960
Lethbridge NL, Chazot PL (2010) Immunological identification of the mouse H4 histamine receptor on spinal cord motor neurons using a novel anti-mouse H4R antibody. Inflamm Res 59(Suppl 1):S197–S198
Leurs R, Chazot PL, Shenton FC, Lim HD, de Esch IJ (2009) Molecular and biochemical pharmacology of the histamine H4 receptor. Br J Pharmacol 157:14–23
Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314:1310–1321
Lim HD, de Graaf C, Jiang W, Sadek P, McGovern PM, Istyastono EP, Bakker RA, de Esch IJP, Thurmond RL, Leurs R (2010) Molecular determinants of ligand binding to H4R species variants. Mol Pharmacol 77:734–743
Liu WL (2014) Histamine H4 receptor antagonists for the treatment of inflammatory disorders. Drug Discov Today 19:1222–1225
Liu C, Wilson SJ, Kuei C, Lovenberg TW (2001) Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 299:121–130
Marson CM (2011) Targeting the histamine H4 receptor. Chem Rev 111:7121–7156
Michel MC, Wieland T, Tsujimoto G (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn-Schmiedeberg’s Arch Pharmacol 379:385–388
Nickel T, Bauer U, Schlicker E, Kathmann M, Göthert M, Sasse A, Stark H, Schunack W (2001) Novel histamine H3-receptor antagonists and partial agonists with a non-aminergic structure. Br J Pharmacol 132:1665–1672
Saligrama N, Noubade R, Case LK, del Rio R, Teuscher C (2012) Combinatorial roles for histamine H1–H2 and H3–H4 receptors in autoimmune inflammatory disease of the central nervous system. Eur J Immunol 42:1536–1546
Sander K, Kottke T, Tanrikulu Y, Proschak E, Weizel L, Schneider EH, Seifert R, Schneider G, Starke G (2009) 2,4-Diaminopyrimidines as histamine H4 receptor ligands—scaffold optimization and pharmacological characterization. Bioorg Med Chem 17:7186–7196
Schlicker E, Göthert M (1998) Interactions between the presynaptic α2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47:129–132
Schlicker E, Behling A, Lümmen G, Göthert M (1992) Histamine H3A-receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg’s Arch Pharmacol 345:489–493
Schlicker E, Malinowska B, Kathmann M, Göthert M (1994) Modulation of noradrenaline release via histamine H3 heteroreceptors. Fundam Clin Pharmacol 8:128–137
Schlicker E, Timm J, Zentner J, Göthert M (1997) Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg’s Arch Pharmacol 356:583–589
Schlicker E, Werthwein S, Zentner J (1999) Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain. Fundam Clin Pharmacol 13:120–122
Seifert R, Strasser A, Schneider EH, Neumann D, Dove S, Buschauer A (2012) Molecular and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci 34:33–58
Shan L, Bossers K, Luchetti S, Balesar R, Lethbridge N, Chazot PL, Bao AM, Swaab DF (2012) Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson’s patients : a postmortem study. Neurobiol Aging 33:1488.e1–13
Strakhova MI, Nikkel AL, Manelli AM, Hsieh GC, Esbenshade TE, Brioni JD, Bitner RS (2009) Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res 1250:41–48
Strange PG (2010) Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors. Br J Pharmacol 161:1238–1249
Szabo B, Schlicker E (2005) Effects of cannabinoids on neurotransmission. Handb Exp Pharmacol 168:327–365
Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn-Schmiedeberg’s Arch Pharmacol 299:123–141
Timm J, Marr I, Wertwein S, Elz S, Schunack W, Schlicker E (1998) H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain. Naunyn-Schmiedeberg’s Arch Pharmacol 357:232–239
Acknowledgements
The financial support of V.S. and E.S. by the faculty programme BONFOR is gratefully acknowledged. We would also like to thank Mrs. D. Petri for her skilled assistance and Schering-Plough Research for a gift of thioperamide.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feliszek, M., Speckmann, V., Schacht, D. et al. A search for functional histamine H4 receptors in the human, guinea pig and mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol 388, 11–17 (2015). https://doi.org/10.1007/s00210-014-1053-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-014-1053-6